ARTICLES BY BETH HARPER
-
The Myth Of Disruptive Innovation In Clinical Trials: Time For A More Disciplined Approach11/21/2019
At the outset, let me state for the record that I’m a big advocate for change. My threshold for accepting “that’s the way we’ve always done things” is actually quite low. But I confess that I’m getting a bit dizzy, dismayed, and, to be frank, disappointed with all the so-called “disruptive innovation” taking place in the industry. First and foremost, I don't really think that anything taking place really qualifies as disruptive.
This website uses cookies to ensure you get the best experience on our website. Learn more